Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 3.9% year on year to $701.3 million. The company’s ...

A Northwestern team transformed a common chemotherapy drug into a powerful, targeted cancer therapy using spherical nucleic ...

Sinead published her first book over twenty years ago and she has looked back on some of the stand out moments of her career ...

Researchers from Nobel Laureate David Baker's lab at the University of Washington have successfully used AI to design ...

AI has the potential to transform life sciences commercialization, but only if we design it around people. Machines bring ...

Genenta Science S.p.A. ADR company and executive profile by Barron's. View the latest K5F company infomation and executive bios.

A new book offers science-based strategies to help you find more love, enjoyment, satisfaction, and meaning in work and life.

Learn about Rani Therapeutics Holdings, Inc.’s innovative oral biologic drug delivery, current drug pipeline, and investment ...

Lise Barnéoud's Hidden Guests shows how this fascinating new field brings with it profound implications for medicine, and ...

At 35, Kiran Desai became the youngest female author to be awarded the Booker prize when her second novel, The Inheritance of ...

Discover why Hims & Hers Health (HIMS) remains a strong long-term buy after robust Q3 growth, new offerings, and expansion ...

Traditional medications are synthesized through chemical reactions, whereas biologics are derived from and reproduced, at ...